Limits Progression of Keratoconus

FDA Approved

Insurance Reimbursement

Avedro’s corneal cross-linking procedure is the first and only therapeutic treatment that stiffens the cornea to slow the progression of the keratoconus.

Learn about Insurance Coverage View Now

1
Minimally Invasive Procedure
2
KXL System for Treatment

What is Cross-Linking?

Corneal collagen cross-linking is the first and only FDA-approved therapeutic treatment for progressive keratoconus that combines the use of ultra-violet light and riboflavin eye drops.

LEARN MORE

Want to See the Difference? View Keratoconus Vision Simulator

Find a Corneal Specialist Near You Search Now

MA-00685D